SCHEMBL9517883

SCHEMBL9517883

CCOCc1ccc(C(=O)NS(=O)(=O)c2cccc3c(OCC)cccc23)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.47
HPGD P15428 3/20 0.41
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
FABP4 P15090 1/20 0.38
CYSLTR1 Q9Y271 1/20 0.38
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
ALOX12 P18054 1/20 0.37
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
GAA P10253 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9519579 0.92 P4HTM (0.47) P4HTMHPGDALDH1A1MEN1KMT2A
SCHEMBL9517123 0.90 P4HTM (0.45) P4HTMHPGDALDH1A1MEN1KMT2A
SCHEMBL9515779 0.90 P4HTM (0.48) P4HTMHPGDALDH1A1MEN1KMT2A
SCHEMBL9517336 0.89 P4HTM (0.44) P4HTMHPGDALDH1A1MEN1KMT2A
SCHEMBL9518028 0.88 FABP4 (0.48) P4HTMHPGDALDH1A1MEN1KMT2A
SCHEMBL9517023 0.88 P4HTM (0.62) P4HTMMEN1KMT2APOLBCYSLTR1
SCHEMBL9515484 0.80 P4HTM (0.43) P4HTM
SCHEMBL9515532 0.79 P4HTM (0.61) P4HTM
SCHEMBL9516931 0.78 FABP4 (0.51) P4HTMALDH1A1LMNAHTTFABP4
SCHEMBL9516257 0.77 P4HTM (0.64) P4HTMMEN1KMT2APOLBCYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed